| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6166637 | Urology | 2015 | 30 Pages |
Abstract
In the National Cancer Data Base, we observed a decrease in the use of RT for patients with RCC from 1998 to 2010. Patients with more aggressive disease characteristics were more likely to receive RT. Well-designed clinical trials are needed to clarify the role of RT in the management of these patients.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Talha Shaikh, Elizabeth A. Handorf, Colin T. Murphy, Alexander Kutikov, Robert G. Uzzo, Mark Hallman, Eric M. Horwitz, Marc C. Smaldone,